Michael A. Jacobetz

9.2k total citations · 4 hit papers
11 papers, 4.6k citations indexed

About

Michael A. Jacobetz is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Michael A. Jacobetz has authored 11 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 2 papers in Cell Biology. Recurrent topics in Michael A. Jacobetz's work include Pancreatic and Hepatic Oncology Research (8 papers), Cancer Cells and Metastasis (3 papers) and Fibroblast Growth Factor Research (2 papers). Michael A. Jacobetz is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Cancer Cells and Metastasis (3 papers) and Fibroblast Growth Factor Research (2 papers). Michael A. Jacobetz collaborates with scholars based in United States, United Kingdom and Germany. Michael A. Jacobetz's co-authors include David A. Tuveson, Sunil R. Hingorani, Tyler Jacks, Catrina E. King, Natalie Cook, Anirban Maitra, Ralph H. Hruban, Martijn P. Lolkema, Christine Feig and Albrecht Neeße and has published in prestigious journals such as The Journal of Experimental Medicine, Cancer Cell and Oncogene.

In The Last Decade

Michael A. Jacobetz

11 papers receiving 4.5k citations

Hit Papers

Preinvasive and invasive ductal pancreatic cancer and its... 2003 2026 2010 2018 2003 2012 2004 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
    2003 1.8k citations Sunil R. Hingorani, Emanuel F. Petricoin et al. Cancer Cell profile →
  2. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
    2012 837 citations Michael A. Jacobetz, Derek Chan et al. Gut profile →
  3. Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects
    2004 626 citations David A. Tuveson, Alice T. Shaw et al. Cancer Cell profile →
  4. Stromal biology and therapy in pancreatic cancer
    2010 604 citations Albrecht Neeße, Patrick Michl et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Jacobetz United States 11 3.1k 2.4k 937 824 769 11 4.6k
Vijaya Ramachandran United States 27 2.1k 0.7× 2.0k 0.8× 941 1.0× 537 0.7× 768 1.0× 46 4.0k
Maximilian Reichert Germany 26 2.2k 0.7× 1.8k 0.7× 897 1.0× 828 1.0× 368 0.5× 58 3.6k
Nicole M. Aiello United States 11 2.1k 0.7× 1.8k 0.8× 1.2k 1.3× 462 0.6× 377 0.5× 15 3.6k
N.V. Rajeshkumar United States 29 2.8k 0.9× 1.9k 0.8× 1.3k 1.4× 393 0.5× 398 0.5× 43 4.3k
Hilary A. Kenny United States 27 1.8k 0.6× 2.6k 1.1× 2.1k 2.3× 396 0.5× 1.1k 1.4× 41 5.4k
Paolo Michieli Italy 28 1.8k 0.6× 2.7k 1.1× 1.1k 1.1× 400 0.5× 355 0.5× 41 4.6k
Daniele V. F. Tauriello Netherlands 19 3.0k 1.0× 2.3k 0.9× 1.1k 1.1× 270 0.3× 1.2k 1.5× 34 4.9k
Agnieszka E. Gorska United States 31 3.0k 1.0× 3.2k 1.3× 799 0.9× 304 0.4× 1.3k 1.7× 48 5.5k
Sergio Palomo‐Ponce Spain 8 2.3k 0.7× 1.9k 0.8× 850 0.9× 235 0.3× 854 1.1× 10 3.9k
Chenwei Li United States 10 2.7k 0.9× 1.9k 0.8× 1.0k 1.1× 270 0.3× 283 0.4× 11 3.6k

Countries citing papers authored by Michael A. Jacobetz

Since Specialization
Citations

This map shows the geographic impact of Michael A. Jacobetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Jacobetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Jacobetz more than expected).

Fields of papers citing papers by Michael A. Jacobetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Jacobetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Jacobetz. The network helps show where Michael A. Jacobetz may publish in the future.

Co-authorship network of co-authors of Michael A. Jacobetz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Jacobetz. A scholar is included among the top collaborators of Michael A. Jacobetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Jacobetz. Michael A. Jacobetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kultti, Anne, Chun‐Mei Zhao, Netai C. Singha, et al.. (2014). Accumulation of Extracellular Hyaluronan by Hyaluronan Synthase 3 Promotes Tumor Growth and Modulates the Pancreatic Cancer Microenvironment. BioMed Research International. 2014. 1–15. 93 indexed citations
2.
Jacobetz, Michael A., Derek Chan, Albrecht Neeße, et al.. (2012). Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 62(1). 112–120. 837 indexed citations breakdown →
3.
Cook, Natalie, Kristopher K. Frese, Tashinga E. Bapiro, et al.. (2012). Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma. The Journal of Experimental Medicine. 209(3). 437–444. 74 indexed citations
4.
DeNicola, Gina M., Carla P. Martins, Michael A. Jacobetz, et al.. (2011). Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene. 31(12). 1599–1608. 64 indexed citations
5.
Bapiro, Tashinga E., Frances M. Richards, Mae A. Goldgraben, et al.. (2011). A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy. Cancer Chemotherapy and Pharmacology. 68(5). 1243–1253. 47 indexed citations
6.
Neeße, Albrecht, Patrick Michl, Christine Feig, et al.. (2010). Stromal biology and therapy in pancreatic cancer. Gut. 60(6). 861–868. 604 indexed citations breakdown →
7.
Flaherty, Keith T., Joan H. Schiller, Lynn M. Schuchter, et al.. (2008). A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel. Clinical Cancer Research. 14(15). 4836–4842. 118 indexed citations
8.
Tuveson, David A., Alice T. Shaw, Nicholas A. Willis, et al.. (2004). Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell. 5(4). 375–387. 626 indexed citations breakdown →
9.
Hingorani, Sunil R., Emanuel F. Petricoin, Anirban Maitra, et al.. (2004). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 5(1). 103–103. 34 indexed citations
10.
Hingorani, Sunil R., Emanuel F. Petricoin, Anirban Maitra, et al.. (2003). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 4(6). 437–450. 1774 indexed citations breakdown →
11.
Hingorani, Sunil R., Michael A. Jacobetz, Gavin P. Robertson, Meenhard Herlyn, & David A. Tuveson. (2003). Suppression of BRAF(V599E) in human melanoma abrogates transformation.. PubMed. 63(17). 5198–202. 334 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijaya Ramachandran Breakdown of academic impact, for papers by Maximilian Reichert Breakdown of academic impact, for papers by Nicole M. Aiello Breakdown of academic impact, for papers by N.V. Rajeshkumar Breakdown of academic impact, for papers by Hilary A. Kenny Breakdown of academic impact, for papers by Paolo Michieli Breakdown of academic impact, for papers by Daniele V. F. Tauriello Breakdown of academic impact, for papers by Agnieszka E. Gorska Breakdown of academic impact, for papers by Sergio Palomo‐Ponce Breakdown of academic impact, for papers by Chenwei Li
Rankless by CCL
2026